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Background: Salmonella resistant to third-generation cephalosporin has been isolated from an increasing number
of animals worldwide. The purpose of this study was to examine ESBL (extended-spectrum β-lactamases)-producing
and PABL (plasmid-mediated AmpC β-lactamases)-producing Salmonella isolates from pigs in South Korea.
Results: Salmonella Typhimurium KVCC-BA1300259 was resistant to ampicillin, amoxicillin/clavulanic acid, cephalothin,
chloramphenicol, florfenicol, cefoxithin, gentamicin, nalidixic acid, trimethoprim/sulfamethoxazole, tetracycline, and
ceftiofur. The results of a double-disk synergy test and PCR confirmed that the isolate produced CMY-2 (PABL).
Analysis of plasmid incompatibility (Inc) groups revealed the presence of IncA/C and IncFIB, indicating antimicrobial
resistance. This study is the first to identify S. Typhimurium isolates harboring CMY-2 in pigs in South Korea.
Conclusions: The presence of CMY-2 in pigs poses a significant threat of possible horizontal spread between animals
and humans.
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Salmonella sp. are important zoonotic pathogens, are
widespread, and can colonize or infect a variety of do-
mesticated and wild animals, including mammals, birds,
and reptiles [1-3]. In pigs, Salmonellosis is an infectious
digestive disease, which presents with acute or chronic
symptoms. Salmonella Choleraesuis and Salmonella Typhi-
murium are the two main causative agents of salmonellosis
worldwide [4]; however, S. Typhimurium is the main cause
of disease in pigs in Korea [5].
Since cephalosphorin was developed as an antimicrobial
agent, an expanded-spectrum cephalosphorin is recom-
mended for the treatment of salmonellosis [6]. However,
Salmonella can produce β-lactamase, which digests third-
generation cephalosphorins and renders them ineffective
[7,8]. Antimicrobial resistance to cephalosphorin is
conferred by extended-spectrum β-lactamases (ESBL)
and plasmid-mediated AmpC β-lactamases (PABL) [9].
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unless otherwise stated.TEM, OXA or SHV-derived ESBL [6,8,10,11]. Recently,
Salmonella has developed resistance to cephalosporin
through the transmission of PABL [12], of which CMY-2
is the most common. CMY-2 was first reported in the
USA and is the most widely distributed PABL, with cases
also reported in France, Germany, Greece and the United
Kingdom; indeed, it was recently isolated from a cow in
Japan and from pigs in China [1,3,12-14]. In most cases,
the CMY-2 gene is present in large plasmids, of which
several genetic types have been reported. Because it is
encoded within a plasmid, CMY-2 can be transmitted
horizontally. Thus, there is increasing concern that PABL
may spread among pathogens circulating in animals and
humans [6].
Here, we isolated CMY-2-producing S. Typhimurium
isolates from diarrheic pigs in South Korea, and examined
the potential horizontal transmission of PABL determi-
nants through plasmids.
Methods
Isolation and identification of Salmonella
Porcine fecal samples were collected from livestock with
digestive disease, such as diarrhea and enteritis by. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Antimicrobial susceptibility of Salmonella
typhimurium isolated from diarrheic pigs
Antimicrobial agent
Salmonella typhimurium (n = 35)
Sa (%) I (%) R (%)
Ampicillin 22.9 - 77.1
Amoxicillin/clavulanic acid 88.6 5.7 5.7
Cephalothin 68.6 17.1 14.3
Chloramphenicol 37.1 2.9 60.0
Florfenicol 28.6 11.4 60.0
Cefoxitin 88.6 5.7 5.7
Gentamicin 28.6 2.8 68.6
Nalidixic acid 28.6 - 71.4
Streptomycinb
Trimethoprim/sulfamethoxazole 65.7 - 34.3
Tetracycline 11.4 - 88.6
Ceftiofur 91.4 2.9 5.7
aS, susceptible; I, intermediate; R, resistant.
bNo CLSI guidelines.
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organization. A total of 483 diarrheal fecal samples were
obtained from nine provinces (Gyeonggi, Gangwon,
Chungbuk, Chungnam, Jeonbuk, Jeonnam, Gyeongbuk,
Gyeongnam, and Jeju) in South Korea from June 2011
to June 2012. Samples were mixed with 45 ml of buff-
ered peptone water and incubated for 20 h at 37°C.
After incubation, 0.1 ml of sample was inoculated into
10 ml Rappaport Vassiliadis R10 broth (RV, Merck,
Germany) and then incubated for 24 h at 42°C. One
loop of RV culture was streaked onto the surface of
XLD agar (Difco, USA) and Salmonella-Shigella agar
(Difco) plates and the suspected colonies were sero-
typed using Salmonella antisera (Denka Seiken, Tokyo,
Japan) according to the method of Ewing [4]. Isolates of
Salmonella sp. were deposited in the Korea Veterinary
Culture Collection (KVCC), where they were stored
at −70°C until further use.
Measurement of minimal inhibitory concentrations and
double-disk synergy tests
Minimal inhibitory concentrations (MICs) were deter-
mined using the standard broth dilution methods de-
scribed in Clinical and Laboratory Standard Institute
(CLSI) guidelines. Escherichia coli ATCC 25922 was
used as a control strain. The double-disk synergy test
(DDST), which is used to detect β-lactamases, was per-
formed with either 30 μg cefotaxime or 30 μg ceftazi-
dime alone, or with either 30 μg cefotaxime or 30 μg
ceftazidime plus 10 μg clavulanic acid according to
CLSI guidelines. The DDST was considered positive
when the inhibition zone produced by the combined ef-
fects of either ceftazidime or cefotaxime plus clavulanic
acid was ≥5 mm larger than that produced by either cef-
tazidime or cefotaxime alone.
Amplification and sequencing of β-lactamases
Multiplex PCR to detect ESBL or PABL genes was per-
formed as described previously [1]. DNA fragments were
separated on a 1% agarose gel. Fragments of the appro-
priate size [1] were extracted from the gel and purified
using a Gel Extraction kit (Qiagen Inc., CA, USA),
followed by sequencing in an ABI Prism 373 Genetic
Analyzer (Applied Biosystems, Foster City, USA) using
Sanger’s method. A database search was then performed
using the BLAST program at NCBI (http://www.ncbi.
nlm.nih.gov).
Conjugation testing
Conjugation with a sodium azide-resistant recipient,
Escherichia coli J53, was performed using broth methods
[9]. Conjugation strains were selected by plating on
MacConkey agar containing 64 mg/L of ceftazidime and
128 mg/L of sodium azide.Plasmid analysis
Plasmid DNA was purified using a Plasmid mini purifi-
cation kit (Qiagen Inc., CA, USA). The BAC-Tracker
supercoiled DNA ladder (Epicentre Biotechnologies Inc.,
WI, USA) was used as a size marker for plasmid analysis.
Plasmids were analyzed using the PCR-based replicon typ-
ing method to identify the plasmid type [15]. All detected
replicon types were confirmed by sequencing.
Results
Forty-four Salmonella sp were isolated from 483 diarrhea
samples. Of these, 35 strains were serotyped as Typhimur-
ium (S. Typhimurium). The standard broth dilution
method was used to determine the antimicrobial suscepti-
bility of S. Typhimurium. The antimicrobial susceptibility
of the 35 S. Typhimurium strains is shown in Table 1.
Two strains (S. Typhimurium KVCC-BA1300259 and S.
Typhimurium KVCC-BA1300271) were resistant to ampi-
cillin, amoxicillin/clavulanic acid, cephalothin, chloram-
phenicol, florfenicol, cefoxithin, gentamicin, nalidixic acid,
trimethoprim/sulfamethoxazole, tetracycline, and ceftiofur
(data not shown). However, S. Typhimurium KVCC-
BA1300259 (isolated in the Chungnam region) was
positive in the DDST, with the zone of inhibition for
ceftazidime plus clavulanic acid being ≥5 mm larger than
that for ceftazidime alone. Thus, KVCC-BA1300259 was
classified as an ESBL-producer. Moreover, genetic analysis
revealed that this isolate produced ESBL and β-lactamase.
PCR with primers specific for CMY-2 amplified an 856 bp
DNA fragment. Sequence analysis of the CMY-2 gene re-
vealed 100% homology with the Salmonella plasmid
CMY-2 AmpC beta-lactamase gene (GenBank accession
no. JN714983).
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transferred to recipient E. coli J53 by conjugation. The
KVCC-BA1300259-TC (transconjugant) was resistant to
chloramphenicol, gentamicin, streptomycin, tetracycline,
ampicillin, amoxicillin/clavulanic acid, cefoxitin, ceftiofur,
and cephalothin (Table 2). PCR detected CMY-2 genes
in both KVCC-BA1300259 and KVCC-BA1300259-TC
(transconjugant).
S. Typhimurium KVCC-BA1300259 and KVCC-BA1300259-
TC harbored a common plasmid ranging from 18 kb to 25 kb
in size, and PCR-based plasmid typing identified the
incompatibility (Inc) type of this plasmid as IncA/C
and IncFIB (Table 2).Discussion
Ceftiofur, which was developed strictly for veterinary
use, is used throughout the world to treat diseased live-
stock [7]. However, animal infection by ESBL-producing
and PABL-producing Salmonella has increased worldwide.
It is thought that these bacteria emerged in response to
the over-use of ceftiofur [6,16].
One hundred and sixty-five Salmonella sp strains were
isolated from cattle in China between 2010 and 2011. Of
these, 25 strains harbored β-lactamases. OXA-1 was the
most commonly identified β-lactamase gene (n = 14),
followed by TEM-1 (n = 6), PSE-1 (n = 4), and CMY-2
(n = 1) [1]. A study of 283 Salmonella sp isolated from
Korean chickens between 2002 and 2010 showed that 17
of the ceftiofur-resistant isolates were positive for genes
encoding CTX-M-14 and CTX-M-15 [9]. Another study
found that two S. Typhimurium strains isolated from
cattle in Japan harbored both TEM-1 and CMY-2 [14].
Plasmid-mediated AmpC-β-lactamases are frequently
identified in human Salmonella isolates in South Korea
[17]; however, until now, CMY-2 has not been isolated
from cattle or pigs. The present study is the first to re-
port the isolation of CMY-2-producing S. Typhimurium
from pigs in South Korea. The potential spread of CMY-2-
producing S. Typhimurium via food, particularly animal-Table 2 Minimum inhibitory concentrations, plasmid replicon
typhimurium isolated from pigs
Strain
Minimum inhibitory concentr
AMP AUG CEP CHL FFN FOX GEN N
S. typhimurium
KVCC-BA1300259
>64 >64/32 >64 >64 >64 >32 >32 >1
S. typhimurium
KVCC-BA1300259-TC
>64 >64/32 >64 >64 >64 >32 >32
E.coli J53 Azider 8 16/8 32 4 <2 4 <1
E.coli ATCC25922 4 4/2 16 4 <2 2 <1 <
AMP: ampicillin; AUG: amoxicillin/clavulanic acid; CEP: cephalothin; CHL: chloramph
STR: streptomycin; SXT: trimethoprim/sulfamethoxazole; TET: tetracycline; XNL: cefti
TC: transconjugant.
Azider: sodium azide resistant.derived foods, has important public health implications
because CMY-2 is usually plasmid-encoded.
These plasmids can be classified according to size,
composition, and incompatibility (Inc) type, and by plas-
mid multilocus sequence typing [12,14,18]. More recently,
the Inc type has been used to classify plasmids. This
method is an important tool for tracking the diffusion of
plasmids conferring antimicrobial resistance [15]. Of the
different Inc types, both IncI1 and IncA/C plasmids were
common carriers. The IncI1 plasmid only carries the
CMY resistance determinant, whereas the IncA/C plas-
mids carry at least one additional determinant. The IncA/
C plasmids carry genes that confer resistance to at least
four antimicrobial agents: chloramphenicol, gentamicin,
streptomycin, and tetracycline [12,14].
Plasmids can be horizontally transmitted between
bacterial populations via conjugation or mobilization.
CMY β-lactamase-encoding plasmids harbored by hu-
man Salmonella isolates in the USA tended to be either
large MDR IncA/C plasmids or IncI1 plasmids harbor-
ing a single resistance determinant [12]. The IncA/C
and IncI1 plasmids were the most common CMY-2 rep-
licon type identified in human Salmonella isolates in
Spain between 2001 and 2005 [6]. The plasmid replicon
types of CMY-2 β-lactamase-producing S. Typhimurium
isolated from a cow in Japan were IncI1 and IncA/C
[14]. However, the plasmids identified in the present study
were IncA/C and IncFIB. IncFIB was a single chimeric
plasmid containing more than one replication type.
Adding antimicrobial agents to animal feed was pro-
hibited in South Korea in July 2011. In the light of the
new regulations, continuous monitoring of antimicrobial
susceptibility in strains isolated from livestock is war-
ranted due to the increasing prevalence of antimicrobial
resistance.
Conclusion
S. Typhimurium isolates from livestock pigs in South
Korea harbored CMY-2, implying the potential transfer
of antimicrobial resistance. This finding suggests thattypes, and β-lactamase genes expressed by Salmonella
ation (μg/ml) Plasmid size (kb)/
β-lactamase
Replicon
typeAL STR SXT TET XNL
28 >128 >4/76 >128 >8 18-25CMY-2 IncA/C IncFIB
4 >128 <0.1/2.3 >128 >8 18-25CMY-2 IncA/C IncFIB
4 8 <0.1/2.3 <2 <0.5
2 4 <0.1/2.3 <2 <0.5
enicol; FFN: florfenicol; FOX: cefoxitin; GEN: gentamicin; NAL: nalidixic acid;
ofur.
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